<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01314924</url>
  </required_header>
  <id_info>
    <org_study_id>CHOC-70</org_study_id>
    <nct_id>NCT01314924</nct_id>
  </id_info>
  <brief_title>Effects of Acute Ingestion of Dark Chocolate on Endothelial Function in Hypertensive Patients</brief_title>
  <official_title>Featuring Treated Hypertensive Patients Who Improve Endothelial Function After Dark Chocolate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Pedro Ernesto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rio de Janeiro State Research Supporting Foundation (FAPERJ)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitario Pedro Ernesto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aimed to identify clinical and vascular parameters of treated hypertensive patients who
      present beneficial effects of dark chocolate for one-week period on vascular function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent findings indicate an inverse relationship between cardiovascular disease and
      consumption of flavonoids. We aimed to identify clinical and vascular parameters of treated
      hypertensive patients who present beneficial effects of dark chocolate for one-week period on
      vascular function. Twenty-one hypertensive patients in drug therapy, both genders, aged 40-65
      years, were included in a prospective study with measurement of blood pressure, brachial
      flow-mediated dilatation (FMD), peripheral arterial tonometry (EndoPAT) and central
      hemodynamic parameters by SphygmoCor. After seven days of eating dark chocolate (70% cocoa)
      75g/day, the clinical and vascular evaluation were repeated. Patients were divided into two
      groups according to the response in FMD: responders (increase in FMD, n=12) and
      non-responders (no improvement in FMD, n=9).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>One week</time_frame>
    <description>Endothelial function evaluated by peripheral arterial tonometry and by flow-mediated dilation of brachial artery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>One week</time_frame>
    <description>Systolic and diastolic blood pressure levels evaluated by an automatic device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central hemodynamic parameters</measure>
    <time_frame>One week</time_frame>
    <description>Aortic systolic blood pressure and pulse pressure evaluated by SphygmoCor. Vascular stiffness parameters such as augmentation pressure and augmentation index will also be evaluated.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Responders</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who present an increase in flow-mediated dilation of brachial artery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non responders</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who do not present an increase in flow-mediated dilation of brachial artery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dark chocolate</intervention_name>
    <description>70% cocoa</description>
    <arm_group_label>Responders</arm_group_label>
    <arm_group_label>Non responders</arm_group_label>
    <other_name>Cocoa</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Previous diagnosis of hypertension

          -  Use of one or two antihypertensive drugs

          -  Systolic blood pressure between 130 and 160 mmHg

          -  Diastolic blood pressure between 85 and 100 mmHg

        Exclusion Criteria:

          -  Secondary hypertension

          -  Diabetes mellitus

          -  Body mass index &gt; 35kg/m2

          -  Chronic kidney disease

          -  Known coronary artery disease

          -  Previous stroke
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jenifer d&quot;El-Rei, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>State University of Rio de Janeiro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Pedro Ernesto</name>
      <address>
        <city>Rio de Janeiro</city>
        <state>RJ</state>
        <zip>20551-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2011</study_first_submitted>
  <study_first_submitted_qc>March 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2011</study_first_posted>
  <last_update_submitted>January 10, 2012</last_update_submitted>
  <last_update_submitted_qc>January 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Pedro Ernesto</investigator_affiliation>
    <investigator_full_name>Mario Fritsch Neves</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Endothelial dysfunction</keyword>
  <keyword>Vascular stiffness</keyword>
  <keyword>Use of one or two antihypertensive drugs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

